arx517
Generic: Anti-PSMA Antibody-drug Conjugate ARX517·Code: ARX517
arx517: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Ambrx Biopharma Cayman, Inc. (AMAM) | Phase 1 |
Get deeper analysis on arx517
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis